Cutting edge: Expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: A possible mechanism of tolerance during NK cell development

Journal of Immunology

Volumn 162, Issue 12, 1999, Pages 6976-6980

  Sivakumar, P V ^a   Gunturi, A ^b   Salcedo, M ^c   Schatzle, J D ^a   Lai, W C ^a   Kurepa, Z ^b   Pitcher, L ^b   Seaman, M S ^b   Lemonnier, F A ^c   Bennett, M ^a   Forman, J ^b   Kumar, V ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD94 ANTIGEN; HLA ANTIGEN;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; FETUS; IMMUNOLOGICAL TOLERANCE; LIVER CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; THYMOCYTE;

AGING; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS; ANTIGENS, CD; ANTIGENS, CD94; ANTIGENS, LY; ANTIGENS, SURFACE; CELL DIFFERENTIATION; CELL-FREE SYSTEM; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; FETUS; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNE SERA; IMMUNE TOLERANCE; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LIVER; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; PROTEINS; SPLEEN; T-LYMPHOCYTES; THYMUS GLAND; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033564932     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Lanier, L. L. 1998. NK cell receptors. Annu. Rev. Immunol. 16:359.
2. Yokoyama, W. M. 1997. What goes up must come down: the emerging spectrum of inhibitory receptors. J. Exp. Med. 186:1803.
3. Brooks, C. G., A. Georgio, and R. K. Jordan. 1993. The majority of immature fetal thymocytes can be induced to proliferate to IL-2 and differentiate into cells indistinguishable from mature NK cells. J. Immunol. 151:6645.
4. Manoussaka, M., A. Georgiou, B. Rossiter, S. Shrestha, J. A. Toomey, P. V. Sivakumar. M. Bennett, V. Kumar, and C. G. Brooks. 1997. Phenotypic and functional characterization of long-lived NK cell lines of different maturational status obtained from mouse fetal liver. J. Immunol. 158:112.
5. + Ly-49 cells can distinguish between major histocompatibility complex class I(hi) and class I(lo) target cells: evidence for a Ly-49-independent negative signaling receptor. Eur. J. Immunol. 27:3100.
6. Toomey, J. A., S. Shrestha, S. A. de la Rue, F. Gays, J. H. Robinson, Z. M. Chrzanowska-Lightowlers, and C. G. Brooks. 1998. MHC class I expression protects target cells from lysis by Ly49-deficient fetal NK cells. Eur. J. Immunol. 28:47.
7. + T cell repertoire and antilymphocytic choriomeningitis virus cytolytic responses. Eur. J. Immunol. 29: 1243.
8. Yu, Y. Y., T. George, J. R. Dorfman, J. Roland, V. Kumar, and M. Bennett. 1996. The role of Ly49A and 5E6(Ly49C) molecules in hybrid resistance mediated by murine natural killer cells against normal T cell blasts. Immunity 4:67.
9. Salcedo, M., P. Bousso, H. G. Ljunggren, P. Kourilsky, and J. P. Abastado. 1998. The Qa-I(b) molecule binds to a large subpopulation of murine NK cells. Eur. J. Immunol. 28:4356.
10. b. J. Immunol. 158:3244.
11. Nakamura, M. C., E. C. Niemi, M. J. Fisher, L. D. Shultz, W. E. Seaman, and J. C. Ryan. 1997. Mouse Ly49A interrupts early signaling events in NK cell cytotoxicity and functionally associates with the SHP-1 tyrosine phosphatase. J. Exp. Med. 185:673.
12. Vance, R. E., D. M. Tanamachi, T. Hanke, and D. H. Raulet. 1997. Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells. Eur. J. Immunol. 27:3236.
13. Ho, E. L., J. W. Hausel, M. G. Brown, K. Matsumoto, A. A. Scalzo, and W. M. Yokoyama. 1998. Murine NKG2D and CD94 are clustered within the natural killer complex and are expressed independently in natural killer cells. Proc. Natl. Acad. Sci. USA 95:6320.
14. Dissen, E., S. F. Berg, I. H. Westgaard, and S. Fossum. 1997. Molecular characterization of a gene in the rat homologous to human CD94. Eur. J. Immunol. 27:2080.
15. b. J. Exp. Med. 188: 1841.
16. Braud, V. M., D. S. Allan, C. A. O'Callaghan, K. Soderstrom, A. D'Andrea, G. S. Ogg, S. Lazetic, N. T. Young, J. I. Bell, J. H. Phillips, L. L. Lanier, and A. J. McMichael. 1998. HLA-E binds to natural killer cell receptors CD94/ NKG2A, B and C. Nature 391:795.
17. b binds conserved class I leader peptides derived from several mammalian species. J. Exp. Med. 188:973.
18. Dorfman, J. R., and D. H. Raulet. 1998. Acquisition of Ly49 receptor expression by developing natural killer cells. J. Exp. Med. 187:609.
19. - cells from multipotential murine bone marrow progenitors in a stroma-free culture: definition of cytokine requirements and developmental intermediates. J. Exp. Med. 186:1609.
20. Colonna, M., F. Navarro, T. Bellon, M. Llano, P. Garcia, J. Samaridis, L. Angman, M. Cella, and M. Lopezbotet. 1997. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 186;1809.
21. Wang, L. L., I. K. Mehta, P. A. LeBlanc, and W. M. Yokoyama. 1997. Mouse natural killer cells express gp49B1, a structural homologue of human killer inhibitory receptors. J. Immunol. 158:13.
22. Mingari, M. C., C. Vitale, C. Cantoni, R. Bellomo, M. Ponte, F. Schiavetti, S. Bertone, A. Moretta, and L. Moretta. 1997. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Eur. J. Immunol. 27:1374.